Wambolt & Associates, LLC Johnson & Johnson Transaction History

Wambolt & Associates, LLC

$342 Million
Q2 2024

A detailed history of Wambolt & Associates, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Wambolt & Associates, LLC holds 18,009 shares of JNJ stock, worth $2.91 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

18,009

Previous 16,087 11.95%

Holding current value

$2.91 Million

Previous $2.54 Million 3.46%

% of portfolio

0.77%

Previous 0.76%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$144.38 - $157.78 $277,498 - $303,253	1,922 Added 11.95%	18,009 $2.63 Million
Q1 2024 Apr 30, 2024	BUY	$155.22 - $162.74 $220,257 - $230,928	1,419 Added 9.67%	16,087 $2.54 Million
Q4 2023 Feb 07, 2024	BUY	$145.6 - $158.88 $91,000 - $99,300	625 Added 4.45%	14,668 $2.3 Million
Q3 2023 Nov 06, 2023	BUY	$155.75 - $174.48 $66,349 - $74,328	426 Added 3.13%	14,043 $2.19 Million
Q2 2023 Aug 02, 2023	BUY	$154.35 - $166.11 $100,327 - $107,971	650 Added 5.01%	13,617 $2.25 Million
Q1 2023 May 05, 2023	SELL	$151.05 - $180.26 $235,789 - $281,385	-1,561 Reduced 10.74%	12,967 $2.01 Million
Q4 2022 Jan 31, 2023	BUY	$160.2 - $179.79 $56,870 - $63,825	355 Added 2.5%	14,528 $2.57 Million
Q3 2022 Oct 18, 2022	BUY	$161.33 - $179.52 $12,745 - $14,182	79 Added 0.56%	14,173 $2.32 Million
Q2 2022 Aug 01, 2022	BUY	$168.19 - $186.01 $51,297 - $56,733	305 Added 2.21%	14,094 $2.5 Million
Q1 2022 May 10, 2022	BUY	$158.14 - $179.59 $106,586 - $121,043	674 Added 5.14%	13,789 $2.46 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $204,736 - $227,162	1,313 Added 11.13%	13,115 $2.24 Million
Q3 2021 Oct 20, 2021	BUY	$161.5 - $179.47 $243,865 - $270,999	1,510 Added 14.67%	11,802 $1.89 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $484,819 - $520,052	3,040 Added 41.92%	10,292 $1.71 Million
Q1 2021 Apr 19, 2021	BUY	$153.07 - $170.48 $186,439 - $207,644	1,218 Added 20.19%	7,252 $1.18 Million
Q4 2020 Jan 19, 2021	BUY	$137.11 - $157.38 $290,947 - $333,960	2,122 Added 54.24%	6,034 $950,000
Q3 2020 Nov 04, 2020	BUY	$140.38 - $153.83 $79,595 - $87,221	567 Added 16.95%	3,912 $582,000
Q2 2020 Jul 23, 2020	BUY	$128.81 - $155.51 $26,534 - $32,035	206 Added 6.56%	3,345 $470,000
Q1 2020 May 11, 2020	BUY	$111.14 - $153.99 $59,348 - $82,230	534 Added 20.5%	3,139 $412,000
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $64,770 - $74,391	508 Added 24.23%	2,605 $380,000
Q3 2019 Oct 15, 2019	BUY	$126.95 - $142.14 $126 - $142	1 Added 0.05%	2,097 $271,000
Q2 2019 Jul 26, 2019	BUY	$131.15 - $144.24 $35,541 - $39,089	271 Added 14.85%	2,096 $292,000
Q1 2019 Apr 11, 2019	SELL	$125.72 - $139.79 $5,280 - $5,871	-42 Reduced 2.25%	1,825 $247,000
Q4 2018 Jan 29, 2019	BUY	$122.84 - $147.84 $229,342 - $276,017	1,867 New	1,867 $241,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $422B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wambolt & Associates, LLC with notifications on news.

Account

Wambolt & Associates, LLC Johnson & Johnson Transaction History